Skip to content
AnalystLens

QUEST DIAGNOSTICS INC Annual Report (Amendment), Year Ended Mar 31, 1997

Filing Date
Filed April 29, 1997
Period End
March 31, 1997
Security
DGX
In the record · 2016–202610-K1110-Q328-K130

DGX filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’16May ’16
  2. Leadership change8-K · Jun ’20Jun ’20
  3. Leadership change8-K · Nov ’22Nov ’22
  4. FY2024 annual report10-K · Feb ’25Feb ’25

Summary

Summary of the 10-K/A filed April 29, 1997. Cited figures are marked; the original filing is the authoritative source.

This is Amendment No. 1 to Quest Diagnostics' (formerly Corning Clinical Laboratories) 10-K for fiscal 1996.

It restates only Part III (directors, executive compensation, security ownership, and related-party transactions) and contains no financial statements, so it offers little on operating results or balance sheet. Investors should read it mainly as governance and transaction disclosure from the company's December 31, 1996 spin-off from Corning Incorporated. As of March 31, 1997, about 29.4 million common shares were outstanding, and non-affiliate market value was roughly $432 milliona.

Corning still held all 1,000 shares of voting cumulative preferred stock. The spin-off and its financing reshaped the company. In the fourth quarter of 1996, Quest borrowed under a new Credit Agreement and issued 10.75% senior subordinated notes due 2006, then paid Corning about $495 millionb from the proceeds.

Corning contributed about $712 millionc, mostly by forgiving intercompany debt, and funded a $119.1 million Damon settlement. Corning also agreed to indemnify Quest for most government fraud and billing penalties tied to pre-distribution periods, and for half of private overbilling settlements above $42.0 million, capped at $25.0 million and lasting five years. Those protections do not cover post-distribution billing claims.

The filing also flags restrictions that matter for future corporate actions. For two years after the distribution, Quest must keep operating its clinical laboratory business and must not take actions such as large equity issuances, repurchases, mergers, or changes to its rights plan that could trigger tax problems for the spin-off.

Quest also indemnifies Corning for taxes if those restrictions are breached, and that exposure could exceed the company's net asset value. Compensation terms are also significant: CEO Kenneth Freeman's employment agreement and change-of-control severance policy could generate large payments.

Key Highlights

  1. Amendment No. 1 restates only Part III (governance and compensation) and contains no financial statements, MD&A, or segment results.
  2. Quest completed its spin-off from Corning on December 31, 1996. Corning distributed all Quest shares to its stockholders, and Quest ceased to be a Corning subsidiary.
  3. In Q4 1996, Quest borrowed under a new Credit Agreement and issued $10.75% senior subordinated notes due 2006. About $495 million of proceeds went to Corning.
  4. Corning funded about $712 million of capital contributions, mainly through forgiveness of intercompany debt, plus $119.1 million for the Damon settlement.
  5. Corning indemnifies Quest for most governmental fraud and billing penalties tied to pre-distribution periods. Its indemnity for private overbilling claims is 50% of amounts above $42.0 million, capped at $25.0 million, and ends five years after distribution.
  6. For two years after the distribution, Quest is restricted from major equity issuances, repurchases, mergers, and rights plan changes that could jeopardize the tax-free spin-off, with indemnification exposure that could exceed net asset value.
  7. Kenneth Freeman's December 1996 employment agreement runs through 1999 with a $500,000 minimum salary. Change-of-control severance can reach three times base salary and three times target bonus for executives under the company's policy.

Frequently Asked Questions

  1. Does this amended 10-K include Quest Diagnostics' financial results for 1996?

    No. Amendment No. 1 replaces only Part III, which covers directors, executive compensation, beneficial ownership, and related-party transactions. Financial statements, revenue, earnings, and cash flow data are not in this filing and would need to be taken from the original 10-K.

  2. How did the spin-off from Corning affect Quest's capital structure and cash position?

    Quest borrowed under a new Credit Agreement and issued $10.75% senior subordinated notes due 2006 in Q4 1996. It paid roughly $495 million of the proceeds to Corning. Corning contributed about $712 million to Quest's capital, mostly through forgiveness of intercompany debt, and funded $119.1 million for the Damon settlement.

  3. How much protection does Corning provide against government and private billing claims?

    Corning indemnifies Quest for monetary penalties and settlements from governmental investigations that were settled or pending as of the distribution date, including qui tam suits filed before that date. For private overbilling claims tied to those governmental matters, Corning covers 50% of amounts above $42.0 million, capped at $25.0 million and limited to five years. Corning does not cover post-distribution governmental claims, consequential damages, or litigation costs.

  4. What tax risks could Quest face from the spin-off?

    If Quest breaches restrictions in its Spin-Off Tax Indemnification Agreement during the two-year restricted period, it must indemnify Corning for resulting taxes. Restricted actions include large equity issuances, repurchases, mergers, liquidation, and certain rights plan changes. The company notes that these indemnification obligations could exceed its net asset value. Under the Tax Sharing Agreement, taxes from a failed distribution may also be allocated among Quest, Corning, and Covance.

  5. What compensation arrangements could create significant payouts for executives?

    CEO Kenneth Freeman's employment agreement runs through December 31, 1999, with a minimum $500,000 salary and at least 65% target bonus. Termination without cause or for good reason pays three times base salary and three times annual bonus. A non-renewal payment equals two times his highest annual cash compensation. Under the severance policy, most other executive officers receive two times base salary and bonus outside a change of control, or three times each within twelve months after one. Freeman's option and restricted stock grants were made in early 1997 under the new Employee Equity Participation Program, which permits up to 3,000,000 shares for employees, excluding substitute options.